DEANXIT Film-coated tablet Ref.[28299] Active ingredients: Flupentixol Melitracen

Source: Υπουργείο Υγείας (CY) Publisher: Lundbeck Hellas A.E., Spyrou Kyprianou, 20 CHAPO CENTRAL, 3rd floor P.C 1075, Nicosia, Cyprus

Product name and form

Deanxit film-coated tablets.

Pharmaceutical Form
Film-coated tablets. Round, biconvex, cyclamen, film-coated tablets.

Qualitative and quantitative composition

Each tablet contains:

Flupentixol 0.5 mg (as 0.584 mg flupentixol dihydrochloride)

Melitracen 10 mg (as 11.25 mg melitracen hydrochloride)

Excipients with known effect:

Lactose monohydrate

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Flupentixol
Melitracen	Melitracen is a tricyclic antidepressant with activating properties in low doses. It has similar pharmacological properties as amitriptyline but is less sedative.

List of Excipients
Tablet core: Betadex Lactose monohydrate Maize starch Hydroxypropylcellulose Microcrystalline cellulose Croscarmellose sodium Talc Hydrogenated vegetable oil Magnesium stearate Coating: Polyvinyl alcohol part. hydrolyzed Macrogol 3350 Talc Titanium dioxide E171 Erythrosine E127 Indigotine E132 Macrogol 6000

Pack sizes and marketing

50 in blister packs.

Marketing authorization holder

Lundbeck Hellas A.E., Spyrou Kyprianou, 20 CHAPO CENTRAL, 3rd floor P.C 1075, Nicosia, Cyprus

Marketing authorization dates and numbers

21765

Date of first authorisation: 31/05/2013
Date of latest renewal: 08/2020

Drugs

Drug	Countries
DEANXIT	Austria, Cyprus, Spain, Hong Kong, Malta, Singapore

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.